Everything You Need to Know About Your Cancer Risk And Physician Led Program to Help You Prevent It

Did you know that 40% of the most common cancers are preventable?(1) That’s why we developed AVRT, a unique telehealth program to help you identify and address the early warning signs of cancer & chronic disease. 

Getting Started is Easy

Reserve your initial telehealth consult with a physician and make your secure online payment. You can review our introductory pricing below. See our introductory pricing below!

Complete your online health questionnaire and we’ll provide you with a test order to get your blood drawn at a Quest Lab near you. 

Attend your online consultation with your physician to review your results and get a personal care plan that tells you what you’re doing well, where you’re at risk, and what you need to do to optimize your health. 

Schedule a Call With an AVRT Representative

Contact us for more information on the program or to speak to an AVRT representative.

By submitting this form, you are confirming that you would like to receive information on the AVRT telehealth program. You can unsubscribe at any time.

By submitting this form, you are confirming that you would like to receive information on the AVRT telehealth program. You can unsubscribe at any time.

Get Deep Insights into Key Metrics that Can Help You Manage Your Risk for
Cancer and Other Chronic Diseases. Here's How it Works.

Limited Time Offer

$599 $330

For a limited time only we are offering our initial health evaluation, physician consult and customized report for only $330

Your Initial Consult Includes:

  • A comprehensive online health evaluation 
  • Access to advanced blood tests to measure for inflammation and metabolic function* 
  • A telehealth consultation with a physician to review your personalized report and health management strategies.
*Please note that the cost of your lab tests are separate from your consultation with the physician, and will be billed separately by the laboratory. Your out-of-pocket costs for lab tests will vary based on your insurance coverage co-pay and deductible, and network status.

Follow Our Podcast "Healthy Conversations"

We recently interviewed Dr. Jason Fung, author of “The Cancer Code,” and member of our Scientific Advisory Board.

In order to help prevent cancer, we first must understand cancer and how it functions. That’s why we have engaged some of the best thought leaders in the field of metabolic pathway disorders, cancer prevention and treatment like Dr. Jason Fung, Dr. Barry Boyd and Benjamin Bikman, Ph.D, to join us in our mission to improve outcomes for cancer and other chronic diseases through early detection and intervention. Learn more from the experts by watching our podcast series, “Healthy Conversations with Travis Christofferson”.

An Experienced Medical Team You Can Access from the Comfort of Your Home
Meet Some of Our Physicians Below

AVRT is led by leading oncologists (cancer specialists) who can provide insights into nutrition, lifestyle modifications and medications to help minimize your risk of developing cancer. Our physicians and scientists are experts in the field of cancer, inflammation and metabolism and develop patient-centric, personalized care plans to optimize patient health. We are committed to the singular goal of prevention: keeping people healthy and reducing the risk of cancer & chronic disease. 

Charles J. Meakin, MD, MHA

Charles J. Meakin, III, M.D., MHA received his medical degree from the University of Cincinnati College of Medicine, followed by a residency in Radiation Oncology at Stanford University Medical Center, Stanford, CA. Board Certified in Radiation Oncology, he also completed a Masters in Health Administration from St. Mary’s College of Moraga, Moraga, CA.

Christy M. Kesslering, M.D.

Christie Kesslering, M.D. received her medical degree from the Stritch School of Medicine, Loyola University, Maywood, IL, followed by a residency in Radiation Oncology at the University of Wisconsin, Madison, WI. She is Board Certified in Radiation Oncology.

Zoraida Mendez, M.D.

Zoraida Mendez, M.D. received her medical degree at Universidad Nacional Pedro Henriquez Urena, Santo Domingo, Dominican Republic, followed by a residency in Internal Medicine at Saint Elizabeth Hospital of Youngstown, OH. She completed her Fellowship in Hematology and Oncology at the Cleveland Clinic Foundation in Cleveland, Ohio.

Paul Zhang, M.D., Ph.D

Paul Zhang, M.D., Ph.D. is a physician-scientist board-certified in medical oncology and internal medicine. Dr. Zhang received his medical degrees from Hebei Medical University and Beijing University. He completed his residency in Internal Medicine at Columbia University, New York, NY, a Clinical Fellowship at Yale University, New Haven, CT and a Cancer Research Fellowship at Memorial Sloan-Kettering Cancer Center, New York, NY.

Advanced Cancer Testing You Can't Access Anywhere Else!

In addition to the AVRT panel performed at your initial consult, your physician can also order advanced blood tests for early cancer detection*. Be sure to ask your AVRT representative about any of the tests below. Pricing and availability vary.


Aristotle is a blood test that uses advanced mRNA technology to identify the molecular signatures of multiple cancers from a single sample of blood. (2)

Learn More


ColonSentry is a blood test that uses advanced mRNA gene expression technology to help identify Colorectal Cancer (CRC) early when it’s most treatable. (3)

Learn More


BreastSentry is a blood test that can help identify if a woman has an increased risk for developing breast cancer. (4)

Learn More


The Prostate Health Index is an FDA approved blood test that can help men with elevated PSA to differentiate benign prostate conditions from prostate cancer. (5,6)

Learn More

* These tests are priced separately and not included in the cost of the AVRT Panel & Physician Consult.


  1. American Institute of Cancer Research (AICR.org) accessed October 28, 2021
  2. Dempsey A, Chao S, Stamatiou D, et al., Aristotle: A single blood test for pan-cancer screening. Journal of Clinical Oncology. 2020; 38:15_suppl, e15037-e15037
  3. Liew CC, Ma J, Tang HC, et al. The peripheral blood transcriptome dynamically reflects system-wide biology: a potential diagnostic tool. J Lab Clin Med. 2006 Mar;147(3):126-32.
  4. Melander O, Belting M, Manjer J, et al. Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer. Cancer Epidemiology and Prevention Biomarkers 23.8 (2014): 1672-1676.
  5. Catalona WJ, Partin AW, Sanda MG, et al. A Multi-Center Study of [−2]Pro-Prostate-Specific Antigen (PSA) in Combination with PSA and Free PSA for Prostate Cancer Detection in the 2.0 to 10.0 ng/mL PSA Range. The Journal of Urology. 2011;185(5):1650-1655.
  6. Loeb S, Sanda MG, Broyles DL, et al. The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer. The Journal of Urology. 2015;193(4):1163-1169